Machine learning in precision diabetes care and cardiovascular risk prediction
Authors:
Top Cited Papers
Open Access
- 25 September 2023
- journal article
- review article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-16
Abstract
Artificial intelligence and machine learning are driving a paradigm shift in medicine, promising data-driven, personalized solutions for managing diabetes and the excess cardiovascular risk it poses. In this comprehensive review of machine learning applications in the care of patients with diabetes at increased cardiovascular risk, we offer a broad overview of various data-driven methods and how they may be leveraged in developing predictive models for personalized care. We review existing as well as expected artificial intelligence solutions in the context of diagnosis, prognostication, phenotyping, and treatment of diabetes and its cardiovascular complications. In addition to discussing the key properties of such models that enable their successful application in complex risk prediction, we define challenges that arise from their misuse and the role of methodological standards in overcoming these limitations. We also identify key issues in equity and bias mitigation in healthcare and discuss how the current regulatory framework should ensure the efficacy and safety of medical artificial intelligence products in transforming cardiovascular care and outcomes in diabetes.Keywords
Funding Information
- National Heart, Lung, and Blood Institute, United States (F32HL170592, K23HL153775)
- Doris Duke Charitable Foundation,United States (2022060)
This publication has 136 references indexed in Scilit:
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- Decision Curve AnalysisJAMA, 2015
- External validation of multivariable prediction models: a systematic review of methodological conduct and reportingBMC Medical Research Methodology, 2014
- A comparison of phenotype definitions for diabetes mellitusJournal of the American Medical Informatics Association, 2013
- Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell, 2012
- Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reportingBMC Medicine, 2011
- Assessing the Performance of Prediction ModelsEpidemiology, 2010
- Avoidable waste in the production and reporting of research evidenceThe Lancet, 2009
- Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 DiabetesJAMA, 2009
- Type 2 Diabetes Mellitus in Midlife Estimated From the Cambridge Risk Score and Body Mass IndexArchives of internal medicine (1960), 2006